Measuring Vasculitis with Numbers: Outcome Scores


Batu E. D. , ÖZEN S.

CURRENT RHEUMATOLOGY REVIEWS, vol.16, no.1, pp.21-28, 2020 (ESCI) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 16 Issue: 1
  • Publication Date: 2020
  • Doi Number: 10.2174/1573397115666191126093927
  • Journal Name: CURRENT RHEUMATOLOGY REVIEWS
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, EMBASE, MEDLINE
  • Page Numbers: pp.21-28
  • Hacettepe University Affiliated: Yes

Abstract

Primary Systemic Vasculitides (PSV) are a heterogeneous group of diseases. Outcome scores are important to evaluate vasculitis patients in a more structured and standard way and these help physicians to predict patients with poor prognosis or high risk of relapse. Furthermore, we need reliable outcome measures for clinical trials. There are a number of vasculitis outcome scores available in the clinical practice with different strengths and limitations. These are mainly measures of disease activity, disease damage, response to treatment and quality of life. Birmingham Vasculitis Activity Score (BVAS) and its pediatric version aim to evaluate a wide scope of PSV. On the other hand, some outcome studies have focused on a single vasculitis type since the whole group includes different diseases with heterogeneous clinical features.